東方甄選(01797.HK)向母企出售教育業務 料錄收益16.5億人幣
東方甄選(01797.HK)公佈,董事會批準建議向母公司新東方集團(09901.HK)(EDU.US)出售教育業務,包括優播香港、酷學慧思及西安睿盈的全部股權等,現金代價合共15億元人民幣(下同),料錄收益16.53億元,所得款項擬用作一般營運資金及發展其餘下業務。
公司指出,出售事項乃廣義新東方集團業務重組的一部分,旨在更明確地劃分其業務線,及更好地使其業務部門與營運環境保持一致。出售事項後,集團及新東方集團所營運的行業將相互區分且各不相同,集團不再經營在線教育領域,而是成爲一家專門的自營產品及直播業務營運商。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.